Biobanks, which store different types of tissue for research purposes, may be covered by HIPAA if they handle protected health information (PHI) as part of a healthcare provider or function as a business associate. However, independent biobanks that solely store de-identified samples may not be covered by HIPAA regulations.
The Health Insurance Portability and Accountability Act (HIPAA) is a U.S. federal law designed to protect individuals’ protected health information (PHI).
According to the U.S. Department of Health and Human Services (HHS), “HIPAA applies to health plans, health care clearinghouses, and those health care providers that conduct certain health care transactions electronically (e.g., billing a health plan). These are known as covered entities...In addition, HIPAA protects PHI held by business associates, such as billing services and others, hired by covered entities to perform services or functions that involve access to PHI.
Both covered entities and business associates are legally required to follow HIPAA’s Privacy and Security Rules, which govern the use, disclosure, and protection of PHI.
Read also: Can you be a covered entity and a business associate?
Biobanks can operate in different contexts:
The key factor in determining whether HIPAA applies to a biobank is whether it handles identifiable protected health information. This includes any biological samples linked to information that can identify the individual donor, such as names, dates of birth, medical record numbers, or genetic data tied to an individual.
If a biobank:
then HIPAA regulations apply. This means the biobank must implement safeguards to protect PHI, control access, and report any breaches as required by law.
If a biobank only collects or stores biological samples that have been de-identified according to HIPAA standards (meaning all identifying information is removed), then HIPAA does not apply because the information is no longer considered PHI.
Independent biobanks that do not receive PHI from covered entities and work exclusively with de-identified or anonymized samples generally fall outside HIPAA’s regulatory scope. However, they may still be subject to:
See also: HIPAA Compliant Email: The Definitive Guide (2025 Update)
PHI includes any information linked to a donor’s identity, such as name, medical record number, genetic data tied to the individual, or any other identifiers.
Compliance protects donor privacy, helps avoid legal penalties, and builds public trust essential for continued research participation.